AI Article Synopsis
- Patients with monoclonal gammopathy of renal significance need specific treatment aimed at targeting the abnormal protein-producing cells.
- This treatment is crucial to stop the condition from worsening and potentially leading to serious complications like advanced monoclonal gammopathies and kidney failure.
- Implementing clone-directed therapy can help preserve kidney function and improve patient outcomes.
Article Abstract
Patients with monoclonal gammopathy of renal significance should be treated with clone-directed therapy against sources of monoclonal proteins in order to prevent progression to more advanced monoclonal gammopathies and renal failure.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562843 | PMC |
| http://dx.doi.org/10.1002/ccr3.3044 | DOI Listing |
Publication Analysis
Top Keywords
rare case
4
case mgrs
4
mgrs immunotactoid
4
immunotactoid glomerulopathy
4
glomerulopathy responding
4
responding bortezomib
4
bortezomib dexamethasone
4
dexamethasone rituximab
4
rituximab patients
4
patients monoclonal
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!